Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
According to the hand holding program it’s a 85% chance of approval
Lmoa
Updated on otc float is 295 million
Dtc held is 315 million
Seems like people that bought in around .03 - .05 are taking profits and still hoping to get back in before news hits. We do have what at least 4-6 weeks before good news comes out. Maybe sooner maybe a little later
I miss tilltom
I agree get those shares in tighter hands
Lol, literally a few weeks from this taking off and they are selling. SMH
Oh well
Hell I’m hoping to buy more under $.10 when I can get more cash in a couple of weeks.
Wasn’t planning on buying more, but in my opinion it’s a no brainer
Here’s to the start of another beautiful green week and one day closer to ide submittal
I’m sure I’ve come across them At one point or another, regardless I’m sure they have a decent following.
I imagine a lot of these will be popping up from here on out. With each one will have their groupies and new investors.
Just as long as they put out the right information bring on the newbie’s.
I agree, one of the main reasons for the new rabbit testing is because they had 8 new members out of the original 11 and had no clue what radiogel was about. So essentially they had to start over. Others will state otherwise.
Right now it’s pretty hard to figure out when to sell. Mainly because of how fast things will start moving after the ide is approved.
Yeah you’ll have the initial run up when they submit the ide, then you’ll have another run up on approval then shortly after that you will have the pr for when they plan to start P1 another run up and then you’ll have the run up when P1 starts then we will have a little bit of quiet time.
So obviously the higher this is sitting before they submit the better off we are,
I’m going to probably hold off as long as possible before I sell part of mine, probably towards the end of the year before I start selling, then I’m looking to sell half and keep the rest on hold until buyout or longer.
At the low think bigger
No time frame mentioned from radiogel, rtg would probably have a good idea on how long that would take.
I will have to disagree with you on that one.
Just with the longs on this board and that have actually disclosed how many shares they have are over 100 million shares alone. And that’s only around 15-20 share holders.
I agree. I don’t think most people realize just how many people are watching this.
And you are right that there will be a run every time news is dropped.
Ide submittal- run up
Ide approval- run up
Announcement of when human trials will start- run up
Phase 1 human trials begin- run up and so on
I still believe isopet will start helping out with the share price as well soon enough might not be anything extraordinary but it will cause a run my opinion of course.
Don’t forget the higher the share the more brokerage firms that invest heavily into biotech/pharmaceutical/medical will be jumping in and those firms will be holding their shares.
Also figure in each major players followers, like Good ole George, love ‘em or hate em he has a pretty large following and that’s just one person.
Now how high after the dust settles on each run who knows. My opinion the first 3 runs will get us a lot more than $2-$3.
Where did you find that
So if your friend buys in he might have to pay quite a bit more to get a good chunk of shares, I’m guessing around $.10 - $.15 a share. Then again if he might lucky
Outstanding shares are 361 million and some change. The float which hasn’t been changed on the otcmarkets site has it sitting at 335 million and some change.
The float hasn’t been updated since January of 2022. So who knows where that is sitting at.
I would say at least 60 - 70% of the shares are locked up by the longs.
Oh I know, and I’m not worried about it, but it definitely opens up to a whole lot more investors and brokerage firms. Just another Avenue the more the merrier.
In the long run for the company and maybe short term it would definitely help them in many ways to get out of the otc.
When the doc first took over he mentioned getting out of the otc and into the nasdaq.
wouldn’t surprise me any if he has it on the list.
Anyone know the rules to join the nasdaq
When this gets approved share structure won’t mean squat.
Oh yeah forgot other uses besides cancer. That throws another log on the fire.
I remember reading that as well. Agree right now there’s just so many options once approved.
Honestly I’m not sure if the doctor will sell after going through all this, he might keep it a bit longer to make sure it gets approved for some of the easier types of cancers to treat, which I would think would take no time at all. And if this happens only god knows how high this will go.
Then again I don’t know if the FDA would do this, but approve it for multiple cancers once they see data and how safe and effective radiogel is on thyroid cancers.
Possible I guess, Would be a question for rtg. If this were to happen right away omg, this will get crazy.
Just to many scenarios for this, better just sit back and get ide approval first.
My opinion ide approval could very well be sitting at $1.50 - $2.00 after the dust settles that will probably swing back and forth until they announce when they will start the human testing then who knows After that.
Remember there’s lots of eyes watching this on the sidelines, there’s also individual brokerages looking for the next big win as well but a lot of brokerages can only invest once it hits a certain amount and then you have ones that can’t even invest in it until it gets out of the otc.
So there’s a lot of stuff that will be happening and don’t forget about isopet as well, if this starts showing signs of consistent revenue and increases as well this can easily effect the share price as well, but for it to make an effect the revenue will have to be pretty significant.
With that being said things will start moving towards the end of March first part of April, maybe sooner. Time will tell. Sit back grab a cigar and a smooth drink and watch the excitement.
If buyout happens more than likely won’t happen phase 2 possibly start of phase 3 human trial and it will be for a lot more than $10 a share.
It did but the amount made was not significant enough to help by any means.
I’m not talking about toxic lending I’m talking about real financing an actual loan with reasonable interest rates.
I agree,
Either way dilution is going to be minimal,
Authorized shares are only 950 million shares the last I checked and outstanding is sitting around 360 million shares. Which for a otc stinky penny play the share structure is in great shape compared to majority of the otc.
This being a otc penny stock, share count won’t effect the share price much if at all.
There’s tons of eyes on this and waiting to jump in and that’s not counting the individual brokerage firms that can’t get in until the share price is higher.
So in short, massive dilution will never happen.
Also don’t forget isopet, granted it might be a little longer before we see any significant revenue from it, but it’s very possible to see decent revenue later this year.
obviously it will depend on where it’s trading At after the dust settles after ide approval. Then how much of a discount the doc wants the offering at. Obviously the higher the share price the better.
My opinion is we will be a lot closer to $1.00 or higher after the dust settles so, possibly the offering will be between $.60-$.75 a share.
Conservative estimate of course
Maybe just maybe they might be able to get actual financing through a bank. Highly unlikely but possible, that will more than likely happen after full approval.
Well how about that. Meeting’s are DONE
They are waiting on the comments from the fda’s review, there easily could be no comments from the fda or they could ask for more clarification on something.
They sent it in for a review for a reason. To make sure the fda was happy with what they have put together.
That’s how I read it. Hmmm seems like RTG knows what he’s talking about. Early second quarter ide submittal I believe is what he said.
Granted the fda could ask for something else, hopefully not.
Start the countdown now
Lmao looks to be some impatient people out there. Oh well their loss
Could be many reasons for the selling.
They owe taxes, tired of waiting, they have another trade expecting to run soon.
Or MMs playing games like they always do. Also a possibility a group pushing the price lower causing some people’s limit low sell order to kick in.
My opinion it’s getting way to close for this to pop and if they are selling to move on another trade and planning on coming back to buy back in at a lower price or in this low range, to me it’s a bit risky to take that chance. March 1st monthly update is next Wednesday. Could be a catalyst of updates coming, well we all know extremely big news is coming we just don’t know when, it could happen March 1st.
Busy start of the day.
Specific testing wasn’t requested until this last October/November far from 15 months ago.
But but but major dilution is going to happen and bankruptcy will follow because I said so